Immunological control of Cryptosporidium infection

Chemical Immunology

Volumn 70, Issue , 1998, Pages 103-123

  McDonald, Vincent ^a   Bancroft, Gregory J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; LEUKOCYTE EXTRACT; MONOCLONAL ANTIBODY; PARASITE ANTIBODY; PARASITE ANTIGEN; SECRETORY IMMUNOGLOBULIN;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN RECOGNITION; CELL CULTURE; CELLULAR IMMUNITY; COLOSTRUM; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREGULATION; IMMUNOTHERAPY; INFECTION CONTROL; INTESTINE EPITHELIUM; MACROPHAGE; MALABSORPTION; NATURAL KILLER CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, PROTOZOAN; CRYPTOSPORIDIOSIS; CYTOKINES; HUMANS; IMMUNITY, NATURAL; IMMUNOTHERAPY; INTERFERON TYPE II; MICE; MICE, NUDE; MICE, SCID; T-LYMPHOCYTES;

EID: 0031985624     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Current WL, Garcia LS: Cryptosporidiosis. Microbiol Rev 1991;4:325-358.
2. Tzipori S: Cryptosporidiosis in perspective. Adv Parasitol 1988;27:63-129.
3. Sherwood DK, Angus KW, Snodgrass DR, Tzipori S: Experimental cryptosporidiosis in laboratory mice. Infect Immun 1982;38:471-475.
4. McDonald V, Robinson HA, Kelly JP, Bancroft GJ: Cryptosporidium muris in adult mice: Adoptive transfer of immunity and roles of CD4 versus CD8 cells. Infect Immun 1994;62:2289-2294.
5. Bancroft GJ, Schreiber RD, Unanue ER: Natural immunity: A T-cell-independent pathway of macrophage activation, defined in the SCID mouse. Immunol Rev 1991;124:5-24.
6. Tripp CS, Wolf SF, Unanue ER: Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin-10 is a physiologic antagonist. Proc Natl Acad Sci USA 1993;90: 3725-3729.
7. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin-12 is required for the T-lymphocyteindependent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-6119.
8. Hunter CA, Subauste CS, Van Cleave VH, Remington JS: Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: Regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun 1994;62:2818-2824.
9. + T lymphocytes in protective immunity. J Immunol 1991;147:1014-1022.
10. McDonald V, Deer R, Uni S, Iseki S, Bancroft GJ: Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID mice). Infect Immun 1992;60:3325-3331.
11. Kuhls S, Greenfield RA, Mosier DA, Crawford DL, Joyce WA: Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency. J Comp Pathol 1992;106:399-410.
12. Mead JR, Arrowood MJ, Sidwell RW, Healey MC: Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J Infect Dis 1991;163:1297-1304.
13. Chen W, Harp JA, Harmsen AG, Havell EA: Gamma interteron functions in resistance to Cryptosporidium parvum infection in severe combined immunodeficient mice. Infect Immun 1993;61:3548-3551.
14. Urban JF Jr, Fayer R, Chen S-J, Gause WC, Gately MK, Finkelman FD: IL-12 protects immuno-competent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol 1996;156:263-268.
15. McDonald V, Bancroft GJ: Mechanisms of innate and acquired immunity in SCID mice infected with Cryptosporidium parvum. Parasite Immunol 1994;16:315-320.
16. Rohlman V, Kuhls T, Mosier D, Crawford D, Greenfield R: Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice. J Parasitol 1993;79:295-297.
17. Sim G-K: Intraepithelial lymphocytes and the immune system. Adv Immunol 1995;58:297-343.
18. Boher Y, Perez-Schael I, Caceres-Dittmar G, Urbina G, Gonzalez R, Kraal G, Tapia FJ: Enumeration of selected leukocytes in the small intestine of BALB/c mice infected with Cryptosporidium parvum. Am J Trop Med Hyg 1994;50:145-151.
19. + cells in response to Cryptosporidium parvum antigen. J Parasitol 1994;80:67-72.
20. Gardner AL, Roche JK, Weikel CS, Guerrant RL: Intestinal cryptosporidiosis: Pathophysiologic alterations and specific cellular and humoral immune responses in RNU/+ and RNU/RNU (athymic) rats. Am J Trop Med Hyg 1991;44:49-62.
21. Heine J, Moon HW, Woodmansee DB: Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect Immun 1984;43:856-859.
22. Ungar BLP, Burris JA, Quinn CA, Finkelman FD: New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect Immun 1990;58:961-969.
23. Mead JR, Arrowood MJ, Healey MC, Sidwell RS: Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J Protozool 1991;38:59S-61S.
24. + cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun 1993;61:3928-3932.
25. Perryman LA, Mason PH, Chrisp CE: Effect of spleen cell populations in resolution of Cryptosporidium parvum infection in SCID mice. Infect Immun 1994;62:1474-1477.
26. Waters WR, Harp JA: Cryptosporidium parvum infection in T-cell receptor (TCR)-α- and TCR-δ-deficient mice. Infect Immun 1996;64:1854-1857.
27. Flanigan T, Whalen C, Turner J, Soave S, Toerner J, Havlir D, Kotler D: Cryptosporidium infection and CD4 counts. Ann Intern Med 1992;116:840-842.
28. Molbak K, Lisse IM, Hojling N, Aaby P: Severe cryptosporidiosis in children with normal T-cell subsets. Parasite Immunol 1994;16:275-277.
29. Aguirre SA, Mason PH, Perryman LE: Susceptibility of major histocompatibility class I- and class II-deficient mice to Cryptosporidium parvum infection. Infect Immun 1994;62:697-699.
30. + intraepithelial lymphocytes. Infect Immun 1996;64:2556-2662.
31. Tilley M, McDonald V, Bancroft GJ: Resolution of cryptosporidial infection in mice correlates with parasite-specific lymphocyte proliferation associated with Th1 and Th2 cytokine secretion. Parasite Immunol 1995;17:459-464.
32. Davami MH, Bancroft GJ, McDonald V: Cryptosporidium infection in MHC congenic strains of mice: Variation in susceptibility and the role of T-cell cytokine responses. Parasitol Res 1997;83:257-263.
33. Kapel N, Benhamou Y, Buraud M, Magne D, Opolon P, Gobert J-G: Kinetics of mucosal ileal gamma-interferon response during cryptosporidiosis in immunocompetent neonatal mice. Parasitol Res 1996;82:664-667.
34. Culshaw RJ, Bancroft GJ, McDonald V: Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving interferon gamma production. Infect Immun 1997;65:3074-3079.
35. Valente GL, Ozmen L, Novelli F, Geuna M, Palestro G, Forni G, Garotta G: Distribution of IFN-γ receptor in human tissues. Eur J Immunol 1992;22:2403-2412.
36. Colgan SP, Parkos CA, Mathhews JB, D'Anrea L, Awtrey CS, Lichtman AH, Delp-Archer C, Madara JL: Interferon-gamma induces a cell surface phenotype switch on T84 intestinal epithelial cells. Am J Physiol 1994;267:C402-C410.
37. Kvale D, Brandtzaeg P, Lovhaug D: Up-regulation of the secretory component and HLA molecules in human colonie cell line by tumor necrosis factor-α and gamma interferon. Scand J Immunol 1988;28:351-357.
38. Rose ME, Wakelin D, Hesketh P: Interferon-gamma-mediated effects upon immunity to coccidial infections in the mouse. Parasite Immunol 1991;13:63-74.
39. Suzuki Y, Conley FK, Remington JS: Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon. Infect Immun 1990;58:3050-3055.
40. Rose ME, Smith AL, Wakelin D: Gamma interferon-mediated inhibition of Eimeria vermiformis growth in cultured fibroblasts and epithelial cells. Infect Immun 1991;59:59-65.
41. Dimier IH, Bout DT: Rat intestinal epithelial cell line IEC-6 is activated by recombinant interferon-γ to inhibit replication of the coccidian Toxoplasma gondii. Eur J Immunol 1993;23:981-983.
42. Cox FEG, Liew FY: T cell subsets and cytokines in parasitic infections. Immunol Today 1992;13: 445-448.
43. Pfefferkorn ER: Interferon-γ blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cell to degrade tryptophan. Proc Natl Acad Sci USA 1984;81:908-912.
44. Kuhls TL, Mosier DA, Abrams VL, Crawford DL, Greenfield RA: Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. J Parasitol 1994;80:480-485.
45. MacDonald TT, Spencer J: Cell-mediated immune injury in the intestine. Gastroenterol Clin North Am 1992;21:367-386.
46. Griffiths JK, Moore R, Dooley S, Keusch GT, Tzipori S: Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability and causes epithelial cell death. Infect Immun 1994;62:4506-4514.
47. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 1996;383: 787-793.
48. + TH1- and TH2-cell-secreted cytokines in cryptosporidiosis. Folia Parasitol 1993;40:307-311.
49. Connolly GM, Owen SL, Hawkins DA, Gazzard BG: Treatment of cryptosporidial infection with recombinant interleukin-2. 5th Int Congr AIDS, Montreal 1989, WBP47, p 359.
50. Harp JA, Moon HW: Susceptibility of mast cell-deficient W/Wv mice to Cryptosporidium parvum. Infect Immun 1991;59:718-720.
51. Ungar BLP, Soave R, Fayer R, Nash TE: Enzyme immunoassay detection of immunoglobulin M and G antibodies to Cryptosporidium in immunocompetent and immunocompromised persons. J Infect Dis 1986;153:570-578.
52. Peeters JE, Villacorta I, Vanopdenbosch E, Vandergheynst D, Naciri M, Ares-Maras E, Yvorre P: Cryptosporidium parvum in calves: Kinetics and immunoblot analysis of specific serum and local antibody responses (immunoglobulin A [IgA], IgG, and IgM) after natural and experimental infections. Infect Immun 1992;60:2309-2316.
53. Hill BD, Blewett DA, Dawson AM, Wright S: Analysis of the kinetics, isotype and specificity of serum and coproantibody in lambs infected with Cryptosporidium parvum. Res Vet Sci 1990;48: 76-81.
54. Williams RO, Burden DJ: Measurement of class specific antibody against Cryptosporidium in serum and faeces from experimentally infected calves. Res Vet Sci 1987;43:264-265.
55. Mead JR, Arrowood MJ, Sterling CR: Antigens of Cryptospordium sporozoites recognized by immune sera of infected animals and humans. J Parasitol 1988;74:135-143,
56. McDonald V, Deer RMA, Nina JMS, Wright S, Chiodini PL, McAdam KPWJ: Characteristics and specificity of hybridoma antibodies against oocyst antigens of Cryptosporidium parvum from man. Parasite Immunol 1991;13:251-259.
57. Tzipori S, Roberton D, Chapman C: Remission of diarrhoea due to cryptosporidiosis in an immuno-deficient child treated with hyperimmune bovine colostrum. Br Med J 1986;293:1276-1277.
58. Ungar BLP, Ward DJ, Fayer R, Quinn CA: Cessation of Crytosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology 1990;98:486-489.
59. Fayer R, Andrews C, Ungar BLP, Blagburn B: Efficacy of hyperimmune bovine colostrum for prophylaxis of cryptosporidiosis in neonatal calves. J Parasitol 1989;75:393-397.
60. Tilley M, Fayer R, Guidry A, Upton SJ, Blagburn BL: Cryptosporidium parvum (Apicomplexa: Cryptosporididae) oocysts and sporozoite antigens recognized by bovine colostral antibodies. Infect Immun 1990;58:2966-2971.
61. Perryman LE, Riggs MW, Mason PH, Fayer R: Kinetics of Cryptosporidium parvum sporozoite neutralization by monoclonal antibodies, immune bovine serum, and immune bovine colstrum. Infect Immun 1990;58:257-259.
62. Arrowood MJ, Mead JR, Mahrt JL, Sterling CR: Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of the Cryptosporidium parvum infections in neonatal mice. Infect Immun 1989;57:2283-2288.
63. Doyle PS, Crabb J, Petersen C: Anti-Cryptosporiduim parvum antibodies inhibit infectivity in vitro and in vivo. Infect Immun 1993;61:4079-4084.
64. Fayer R, Guidry A, Blagburn BL: Immunotherapeutic efficacy of bovine colostral immunoglobulins from a hyperimmunized cow against cryptosporidiosis in neonatal mice. Infect Immun 1990;58: 2962-2965.
65. Riggs MW, Cama VA, Leary HL Jr, Sterling CR: Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect Immun 1994;62:1927-1939.
66. Petersen C, Gut J, Leech JH, Nelso RG: Identification and initial characterization of five Cryptosporidium parvum antigen genes. Infect Immun 1992;60:2343-2348.
67. r Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin. Infect Immun 1992;60:5132-5138.
68. Bjorneby JM, Riggs MW, Perryman LE: Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites. J Immunol 1990;145:298-304.
69. Tilley M, Upton SJ, Fayer R, Barta JR, Chrisp CE, Freed PS, Blagburn BL, Anderson BC, Barnard SM: Identification of a 15-kilodalton surface glycoprotein on sporozoites of Cryptospordium parvum. Infect Immun 1991;59:1002-1007.
70. McDonald V, McCrossan MV, Petry F: Localization of parasite antigens in Cryptosporidium parvum-infected epithelial cells using monoclonal antibodies. Parasitology 1995;110:259-268.
71. Cozon G, Biron F, Jeannin M, Cannella D, Revillard J-P: Secretory IgA antibodies to Cryptosporidium parvum in AIDS patients with chronic cryptosporidiosis. J Infect Dis 1994;169:696-699.
72. Saxon A, Weinstein W: Oral administration of bovine colostrum anti-cryptosporidia antibody fails to alter the course of human cryptosporidiosis. J Parasitol 1987;73:413-415.
73. Moon HW, Woodmansee HW, Harp JA, Abel S, Ungar BLP: Lacteal immunity to enteric cryptosporidiosis in mice: Immune dams do not protect their suckling pups. Infect Immun 1988;56:649-653.
74. Taghi-Kilani R, Sekla L, Hayglass KT: The role of humoral immunity in Cryptosporidium spp. infection studies with B-cell-depleted mice. J Immunol 1990;145:1571-1576.
75. Albert MM, Rusnak J, Luther MF, Graybill JR: Treatment of murine cryptosporidiosis with anticryptosporidial immune rat bile. Am J Trop Med Hyg 1994;50:112-119.
76. Cama VA, Sterling CR: Hyperimmune hens as a novel source of anti-Cryptosporidium antibodies suitable for passive immune transfer. J Protozool 1991;38:42S-43S.
77. McMeeking A, Borkowsky W, Klesius PH, Bonk S, Holzman RS, Lawrence HS: A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J Infect Dis 1990;161:108-112.
78. Fayer R, Klesius PH, Andrews C: Efficacy of bovine transfer to protect neonatal calves against experimentally induced clinical cryptosporidiosis. J Parasitol 1987;73:1061-1062.
79. Gooi HC: Gastrointestinal and liver involvement in primary immunodeficiency; in Heatley RV (ed): Gastrointestinal and Hepatic Immunology. Cambridge Rev Clin Immunol. Cambridge, Cambridge University Press, 1994, pp 169-177.